Close
  Indian J Med Microbiol
 

Figure 10 Biofilm inhibition ratio of proteases produced by Bacillus licheniformis wild type (WT) and mutants (M2, M4, and M26) against four clinical microbes (Pseudomonas aeruginosa, Staphylococcus aureus, Escherichia coli, and Bacillus subtilis). Biofilm was quantified using the microtiter plate test and crystal violet assay. The bars on the graph represent mean±SD as a percentage of biofilm inhibition.

Figure 10 Biofilm inhibition ratio of proteases produced by <i>Bacillus licheniformis</i> wild type (WT) and mutants (M2, M4, and M26) against four clinical microbes (<i>Pseudomonas aeruginosa</i>, <i>Staphylococcus aureus</i>, <i>Escherichia coli</i>, and <i>Bacillus subtilis</i>). Biofilm was quantified using the microtiter plate test and crystal violet assay. The bars on the graph represent mean±SD as a percentage of biofilm inhibition.